Serum levels of high mobility group box 1 correlate with disease severity in recessive dystrophic epidermolysis bullosa
暂无分享,去创建一个
J. McGrath | J. Mellerio | G. Petrof | L. Proudfoot | John A McGrath | Gabriela Petrof | Alya Abdul-Wahab | Laura Proudfoot | Rashida Pramanik | Jemima E Mellerio | R. Pramanik | A. Abdul‐Wahab
[1] T. Ghaly,et al. HMGB1 in renal ischemic injury. , 2012, American journal of physiology. Renal physiology.
[2] A. Coyle,et al. HMGB1 and RAGE in inflammation and cancer. , 2010, Annual review of immunology.
[3] K. Tamai,et al. Japanese guidelines for diagnosis and treatment of junctional and dystrophic epidermolysis bullosa , 2003, Archives of Dermatological Research.
[4] C. Moss,et al. The Birmingham Epidermolysis Bullosa Severity score: development and validation , 2009, The British journal of dermatology.
[5] M. Churchill,et al. The high mobility group box: the ultimate utility player of a cell. , 2012, Trends in biochemical sciences.
[6] E. Bauer,et al. The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB. , 2008, Journal of the American Academy of Dermatology.
[7] D. Murrell,et al. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa , 2008, Experimental dermatology.
[8] Y. Kaneda,et al. PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia , 2011, Proceedings of the National Academy of Sciences.
[9] M. Bianchi,et al. High‐mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity , 2007, Immunological reviews.
[10] M. Aria,et al. Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment. , 2013, Journal of the American Academy of Dermatology.
[11] J. Mellerio,et al. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. , 2009, Journal of the American Academy of Dermatology.
[12] M. Tohyama,et al. High-mobility group box 1 protein (HMGB1) as a novel diagnostic tool for toxic epidermal necrolysis and Stevens-Johnson syndrome. , 2011, Archives of dermatology.
[13] J. Mellerio,et al. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. , 2009, Journal of the American Academy of Dermatology.
[14] J. Uitto,et al. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. , 2010, Dermatologic clinics.
[15] J. Wagner,et al. Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls , 2012, Experimental dermatology.